Linjin Li
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Rehabilitation top 10%
- Exercise and Physiological Responses
Papers in
-
- RNA modifications and cancer 2
- Genomics, phytochemicals, and oxidative stress 2
-
- Prostate Cancer Treatment and Research 2
- Co-authors
- Zhiliang Weng (2 shared papers)Yiren Hu (2 shared papers)Zhiqiang Zheng (1 shared paper)Senrui Chen (1 shared paper)Jun Zou (1 shared paper)Rong Zhu (1 shared paper)Xi Chen (1 shared paper)Jiake Xu (1 shared paper)
- Journals
- Journal of environmental chemical engineering (2 papers)Frontiers in Public Health (2 papers)Anti-Cancer Agents in Medicinal Chemistry (1 paper)Journal of Endourology (1 paper)Food Chemistry (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Linjin Li
19 papers receiving 347 citations
Peers
Comparison fields: 5 of 95
- Cancer Research 158
- Rehabilitation 48
- Orthopedics and Sports Medicine 45
- Complementary and alternative medicine 24
- Obstetrics and Gynecology 21
Countries citing papers authored by Linjin Li
This map shows the geographic impact of Linjin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linjin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linjin Li more than expected).
Fields of papers citing papers by Linjin Li
This network shows the impact of papers produced by Linjin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linjin Li. The network helps show where Linjin Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Linjin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 88 | |
| 2 | 2017 | 77 | |
| 3 | Long noncoding RNA GHET1 promotes the development of bladder cancer. | 2014 | 67 |
| 4 | 2015 | 35 | |
| 5 | Papaverine selectively inhibits human prostate cancer cell (PC-3) growth by inducing mitochondrial mediated apoptosis, cell cycle arrest and downregulation of NF-κB/PI3K/Akt signalling pathway. | 2017 | 21 |
| 6 | 2021 | 11 | |
| 7 | 2025 | 9 | |
| 8 | 2019 | 9 | |
| 9 | 2025 | 8 | |
| 10 | 2025 | 6 | |
| 11 | 2023 | 5 | |
| 12 | 2022 | 4 | |
| 13 | 2025 | 3 | |
| 14 | 2018 | 3 | |
| 15 | 2025 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2024 | 0 |
About Linjin Li
Linjin Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Biomedical Engineering and Materials Chemistry, having authored 24 papers that have together received 351 indexed citations. Recurring topics across this work include Advanced oxidation water treatment (3 papers), Prostate Cancer Treatment and Research (2 papers), Electrocatalysts for Energy Conversion (2 papers), RNA modifications and cancer (2 papers), Environmental remediation with nanomaterials (2 papers), Cancer-related molecular mechanisms research (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Catalytic Processes in Materials Science (2 papers). The work is most often cited by research in Cancer Research (158 citations), Rehabilitation (48 citations), Orthopedics and Sports Medicine (45 citations), Complementary and alternative medicine (24 citations) and Obstetrics and Gynecology (21 citations). Linjin Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Zhiliang Weng, Yiren Hu, Zhiqiang Zheng, Senrui Chen, Jun Zou, Rong Zhu, Xi Chen, Jiake Xu, Jianmin Guo and Feng Wang. Their work appears in journals such as Journal of environmental chemical engineering, Frontiers in Public Health, Anti-Cancer Agents in Medicinal Chemistry, Journal of Endourology and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.